Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EMBC

Embecta Corp

May 05 • 04:00PM ET

3.90

-5.35 -57.84 %

Healthcare • Medical Instruments & Supplies • USA • Micro • NASD

May 05, 1:53 PMEmbecta Q2 2026 EPS $0.27 (-61% YoY), revenue $221.8M (-14% YoY) miss as 2026 guidance cut sharply on U.S. pen needle collapse

Peers: DXCM PODD TNDM ABT MDT LCTX VTRS BAX BMY MRK

| Held by: IJR VTI IWM VXF IJS SPSM FNDA IWN SLYV DES

Scroll to Statements

Index	RUT	P/E	1.64	EPS (ttm)	2.37	Insider Own	8.18%	Shs Outstand	59.33M	Perf Week	-56.81%
Market Cap	230.96M	Forward P/E	1.52	EPS next Y	2.57	Insider Trans	0.00%	Shs Float	54.38M	Perf Month	-56.33%
Enterprise Value	1.40B	PEG	-	EPS next Q	0.68	Inst Own	102.88%	Short Float	10.67%	Perf Quarter	-64.25%
Income	139.50M	P/S	0.22	EPS this Y	-15.26%	Inst Trans	3.38%	Short Ratio	5.19	Perf Half Y	-70.76%
Sales	1.04B	P/B	-	EPS next Y	2.69%	ROA	12.61%	Short Interest	5.80M	Perf YTD	-67.17%
Book/sh	-10.55	P/C	1.19	EPS next 5Y	-3.94%	ROE	-	52W High	15.55 -74.92%	Perf Year	-68.70%
Cash/sh	3.27	P/FCF	1.12	EPS past 3/5Y	-25.52% -	ROIC	19.41%	52W Low	8.47 -53.96%	Perf 3Y	-86.63%
Dividend Est.	0.60 (15.39%)	EV/EBITDA	3.50	Sales past 3/5Y	-1.47% -0.10%	Gross Margin	62.86%	Volatility	9.59% 4.89%	Perf 5Y	-
Dividend TTM	0.60 (15.38%)	EV/Sales	1.34	EPS Y/Y TTM	136.26%	Oper. Margin	30.14%	ATR (14)	0.70	Perf 10Y	-
Dividend Ex-Date	May 28, 2026	Quick Ratio	1.87	Sales Y/Y TTM	-3.43%	Profit Margin	13.38%	RSI (14)	14.40	Recom	2.80
Dividend Gr. 3/5Y	58.74% -	Current Ratio	2.64	EPS Q/Q	-117.21%	SMA20	-56.43%	Beta	1.07	Target Price	11.50
Payout	37.05%	Debt/Eq	-	Sales Q/Q	-14.36%	SMA50	-57.17%	Rel Volume	18.15	Prev Close	9.25
Employees	1850	LT Debt/Eq	-	Earnings	May 05 BMO	SMA200	-67.10%	Avg Volume	1.12M	Price	3.90
IPO	Mar 22, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	-35.25% -5.89%	Trades		Volume	16,130,718	Change	-57.84%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Neutral	$15
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

May-05-26 04:53PM	Embecta Corp. Q2 2026 Earnings Call Summary (Moby) -57.84%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results (GlobeNewswire)
06:30AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Apr-21-26 05:00PM	embecta to Report Fiscal Second Quarter Financial Results (GlobeNewswire)
Mar-20-26 06:35AM	Embecta agrees to acquire Owen Mumford (Medical Device Network)
10:37AM	Loading…
Mar-19-26 10:37AM	Embecta to buy Owen Mumford for up to $201M (MedTech Dive)
06:30AM	embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited (GlobeNewswire)
Feb-11-26 04:10PM	embecta names new Chairman of the Board and Lead Independent Director (GlobeNewswire)
Feb-05-26 05:30PM	Embecta Q1 Earnings Call Highlights (MarketBeat) -7.75%
02:02PM	Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-22-26 05:00PM	embecta to Report Fiscal First Quarter Financial Results (GlobeNewswire) -9.44%
Dec-18-25 05:00PM	embecta to Participate at the J.P. Morgan 2026 Healthcare Conference (GlobeNewswire)
Nov-25-25 02:01PM	Embecta Corp (EMBC) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) -7.24%
06:30AM	Loading…
06:30AM	Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-20-25 07:50AM	EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? (Zacks)
Nov-17-25 05:00PM	embecta announces changes to Board of Directors (GlobeNewswire)
Nov-14-25 06:30AM	embecta Announces Major New Commitment to Direct Relief on World Diabetes Day (GlobeNewswire)
Nov-11-25 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Oct-06-25 05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
Sep-15-25 08:06AM	Best Income Stocks to Buy for September 15th (Zacks)
05:37AM	New Strong Buy Stocks for September 15th (Zacks)
Sep-09-25 04:12AM	Best Value Stocks to Buy for September 9th (Zacks)
Aug-26-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Aug-25-25 09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Aug-12-25 09:55AM	Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know (Zacks)
Aug-09-25 03:03AM	Embecta Corp (EMBC) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Progress ... (GuruFocus.com)
Aug-08-25 06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire) +18.53%
06:00AM	Loading…
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-24-25 05:00PM	embecta to Report Fiscal Third Quarter 2025 Financial Results (GlobeNewswire)
Jul-13-25 12:27AM	BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating (Insider Monkey)
Jul-10-25 11:13AM	Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating (Insider Monkey)
May-27-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +5.09% -6.31%
May-22-25 06:30AM	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire) -14.97%
May-13-25 10:50AM	Embecta restructures again, outlines tariff costs (MedTech Dive)
May-10-25 05:16AM	Q2 2025 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
May-09-25 12:10PM	Why Is Embecta Stock Falling On Friday? (Benzinga) -10.00%
07:40AM	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-08-25 05:15PM	Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates (Zacks) +6.66%
May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
Apr-28-25 07:30AM	Embecta to host Analyst and Investor Day on May 22, 2025 (GlobeNewswire)
Apr-22-25 03:51AM	Beyond the drug: Closing the knowledge gap for injectable diabetes meds (Pharma Voice)
Apr-21-25 05:00PM	embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire)
Apr-01-25 08:05AM	Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations (GlobeNewswire)
Feb-19-25 03:36PM	Embecta Corp. (EMBC): Among Last Weeks Worst Dividend Stocks (Insider Monkey)
Feb-18-25 05:00PM	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire)
Feb-07-25 02:09AM	Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Feb-06-25 07:45AM	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-23-25 05:00PM	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire)
Dec-19-24 05:00PM	embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%
07:40AM	Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-24 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline (Zacks)
Jul-31-24 09:47AM	Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock? (Zacks)
Jul-29-24 08:05AM	Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company (PR Newswire)
Jul-24-24 04:21AM	Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Jul-22-24 07:42AM	Diabetes device firm Embecta considers sale: Financial Times (MedTech Dive) +15.26%
Jul-18-24 05:00PM	embecta to Report Fiscal Third Quarter 2024 Financial Results (GlobeNewswire)
Jun-25-24 07:47AM	Embecta touts its insulin patch pump at ADA (MedTech Dive)
Jun-24-24 06:30AM	embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir (GlobeNewswire)
Jun-20-24 07:30AM	Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors (PR Newswire)
May-21-24 04:30PM	Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs (InvestorPlace)
May-13-24 11:52AM	Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 02:12PM	Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024 (GuruFocus.com)
May-09-24 10:54AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +37.88%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Apr-23-24 05:00PM	embecta to Report Fiscal Second Quarter 2024 Financial Results (GlobeNewswire)
Mar-06-24 06:00AM	embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes (GlobeNewswire)
Feb-10-24 08:55AM	Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript (Insider Monkey)

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Melcher David F	Director	May 23 '25	Buy	10.60	10,000	105,995	86,681	May 23 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EMBC

Embecta Corp

Upgrade your Finviz experience